Production of osteoprotegerin by prostate cancer cells suppresses trial induced apoptosis

Author： Holen I. Eaton C. Hamdy F. Croucher P.

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.1, Iss.1, 2002-01, pp. : 54-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteoprotegerin and rank ligand expression in prostate cancer

By Brown J.M. Corey E. Lee Z.D. True L.D. Yun T.J. Tondravi M. Vessella R.L.

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 611-616

Elsevier

Access to resources Recommend Favorite

E1A oncogene expression inhibits PTHrP P3 promoter activity and sensitizes human prostate cancer cells to TNF-induced apoptosis

By Asadi Farrokh

International Urology and Nephrology, Vol. 42, Iss. 4, 2010-12 ,pp. : 971-978

Springer Publishing Company

Access to resources Recommend Favorite

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis - a European multicenter follow-up study

By Goluboff E.T. Shabsigh A. Saidi J.A. Weinstein I.B. Mitra N. Heitjan D. Piazza G.A. Pamukcu R. Buttyan R. Olsson C.A.

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 440-445

Elsevier

Access to resources Recommend Favorite

Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line

By Panvichian R. Orth K. Pilat M.J. Day M.L. Day K.C. Yee C. Kamradt J.M. Pienta K.J.

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 746-752

Elsevier

Access to resources Recommend Favorite

Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis - elimination of a BAD influence

By Reyes-Moreno C. Sourla A. Chpki I. Doillon C. Koutsilieris M.

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 341-347

Elsevier

Access to resources Recommend Favorite